JP2021046360A5 - - Google Patents

Download PDF

Info

Publication number
JP2021046360A5
JP2021046360A5 JP2019168668A JP2019168668A JP2021046360A5 JP 2021046360 A5 JP2021046360 A5 JP 2021046360A5 JP 2019168668 A JP2019168668 A JP 2019168668A JP 2019168668 A JP2019168668 A JP 2019168668A JP 2021046360 A5 JP2021046360 A5 JP 2021046360A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
group
gene product
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019168668A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021046360A (ja
JP7397467B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2019168668A priority Critical patent/JP7397467B2/ja
Priority claimed from JP2019168668A external-priority patent/JP7397467B2/ja
Priority to US17/024,435 priority patent/US12138253B2/en
Publication of JP2021046360A publication Critical patent/JP2021046360A/ja
Publication of JP2021046360A5 publication Critical patent/JP2021046360A5/ja
Application granted granted Critical
Publication of JP7397467B2 publication Critical patent/JP7397467B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019168668A 2019-09-17 2019-09-17 腫瘍抑制剤 Active JP7397467B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2019168668A JP7397467B2 (ja) 2019-09-17 2019-09-17 腫瘍抑制剤
US17/024,435 US12138253B2 (en) 2019-09-17 2020-09-17 Tumor suppression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019168668A JP7397467B2 (ja) 2019-09-17 2019-09-17 腫瘍抑制剤

Publications (3)

Publication Number Publication Date
JP2021046360A JP2021046360A (ja) 2021-03-25
JP2021046360A5 true JP2021046360A5 (cg-RX-API-DMAC7.html) 2022-09-13
JP7397467B2 JP7397467B2 (ja) 2023-12-13

Family

ID=74877763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019168668A Active JP7397467B2 (ja) 2019-09-17 2019-09-17 腫瘍抑制剤

Country Status (2)

Country Link
US (1) US12138253B2 (cg-RX-API-DMAC7.html)
JP (1) JP7397467B2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021246332A1 (ja) * 2020-06-02 2021-12-09 株式会社キノファーマ ウシパピローマウイルスに起因する牛乳頭腫症の治療、改善、及び/又は進行抑制用組成物
WO2023214568A1 (ja) 2022-05-02 2023-11-09 株式会社キノファーマ アニリン誘導体を含有する皮膚用外用剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2666481T3 (en) * 2003-12-26 2019-02-25 Masatoshi Hagiwara A method for regulating the phosphorylation of SR protein and antiviral agents comprising an SR protein activity regulator as the active ingredient
WO2009020198A1 (ja) * 2007-08-03 2009-02-12 Kinopharma, Inc. 抗dnaウイルス作用を有するアニリン誘導体
BR112015022861A8 (pt) * 2013-03-11 2019-11-26 Abbvie Inc inibidores de bromodomínio
JP6919891B2 (ja) * 2017-08-23 2021-08-18 国立大学法人島根大学 Epstein−Barrウイルス関連癌に特異的な抗腫瘍剤

Similar Documents

Publication Publication Date Title
RU2007116119A (ru) Производные циклоспорина, замещенные 3-эфиром и 3-тиоэфиром, для лечения и профилактики инфекционного гепатита с
JP2008514732A5 (cg-RX-API-DMAC7.html)
JP2019500387A5 (cg-RX-API-DMAC7.html)
US6248782B1 (en) Method of treating viral diseases
JP2013056886A5 (cg-RX-API-DMAC7.html)
JP2005523922A5 (cg-RX-API-DMAC7.html)
CA2490200A1 (en) 2' and 3'-nucleoside prodrugs for treating flaviviridae infections
JP2009537550A5 (cg-RX-API-DMAC7.html)
JP2009531403A5 (cg-RX-API-DMAC7.html)
CA2615921A1 (en) Hepatitis c inhibitor peptide analogs with a quinoline or a thienopyridine moiety
JP2010530881A5 (cg-RX-API-DMAC7.html)
JP2013523765A5 (cg-RX-API-DMAC7.html)
JP2012519691A5 (cg-RX-API-DMAC7.html)
JP2005505499A5 (cg-RX-API-DMAC7.html)
JP2005526857A5 (cg-RX-API-DMAC7.html)
JP2010501584A5 (cg-RX-API-DMAC7.html)
JP2005533040A5 (cg-RX-API-DMAC7.html)
JP2004509061A5 (cg-RX-API-DMAC7.html)
JP2021028338A5 (cg-RX-API-DMAC7.html)
JP2005508962A5 (cg-RX-API-DMAC7.html)
WO2017114812A1 (en) Combination therapy of an hbsag inhibitor and an interferon
JP2005525991A5 (cg-RX-API-DMAC7.html)
JP2007520452A5 (cg-RX-API-DMAC7.html)
RU2008139195A (ru) Замещенные арилсульфанамиды как противовирусные средства
JP2018520147A5 (cg-RX-API-DMAC7.html)